You have 9 free searches left this month | for more free features.

Lipidoses

Showing 1 - 23 of 23

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cholesterol; Lipidosis Trial in Kansas City (Rosuvastatin 10mg)

Recruiting
  • Cholesterol; Lipidosis
  • Rosuvastatin 10mg
  • Kansas City, Missouri
    Children's Mercy Hospital
Jul 1, 2022

Sphingomyelin Lipidosis Trial (olipudase alfa (GZ402665))

Approved for marketing
  • Sphingomyelin Lipidosis
  • olipudase alfa (GZ402665)
  • (no location specified)
Sep 15, 2022

Lipid Storage Disease Trial in Istanbul

Not yet recruiting
  • Lipid Storage Disease
    • Istanbul, Turkey
      Istanbul University
    Mar 29, 2022

    Hypertension, Diet, Healthy, Body Weight Trial in Elche (CONTROL GROUP, HEALTH APP GROUP)

    Active, not recruiting
    • Hypertension
    • +5 more
    • CONTROL GROUP
    • HEALTH APP GROUP
    • Elche, Alicante, Spain
      NutriciĆ³n Selecta
    Nov 18, 2021

    Cholesterol; Lipidosis Trial in Subang Jaya (Mindfulness practice)

    Recruiting
    • Cholesterol; Lipidosis
    • Mindfulness practice
    • Subang Jaya, Selangor, Malaysia
      Monash University Malaysia
    Apr 6, 2021

    Sphingomyelin Lipidosis Trial in Worldwide (Olipudase alfa)

    Completed
    • Sphingomyelin Lipidosis
    • Olipudase alfa
    • New York, New York
    • +5 more
    Mar 15, 2022

    IBD, Crohn Disease, Polyunsaturated Acid Lipidosis Trial (azathioprine, infliximab, N-3 Polyunsaturated Fatty Acids)

    Not yet recruiting
    • Inflammatory Bowel Diseases
    • +2 more
    • (no location specified)
    Feb 18, 2021

    Krabbe Disease Trial in Ann Arbor (FBX-101)

    Recruiting
    • Krabbe Disease
    • FBX-101
    • Ann Arbor, Michigan
      University of Michigan Hospitals - Michigan Medicine
    Feb 13, 2023

    Metabolism, Inborn Errors, Lipid Metabolism, Inborn Errors, Carbohydrate Metabolism, Inborn Errors Trial in Copenhagen (Sugar)

    Unknown status
    • Metabolism, Inborn Errors
    • +22 more
    • Sugar
    • Copenhagen, Denmark
      Neuromuscular Research Unit, 3342
    Oct 15, 2019

    Primary Triglyceride Deposit Cardiomyovasculopathy (TGCV), Neutral Lipid Storage Disease With Myopathy (NLSD-M) Trial in Italy,

    Terminated
    • Primary Triglyceride Deposit Cardiomyovasculopathy (TGCV)
    • Neutral Lipid Storage Disease With Myopathy (NLSD-M)
    • CNT-02
    • Rome, Lazio, Italy
    • +6 more
    Jul 4, 2019

    Lyso-Gb1 as a Long-term Prognostic Biomarker in Gaucher Disease

    Completed
    • Lysosomal Storage Diseases
    • +2 more
      • Tirana, Albania
      • +7 more
      May 27, 2021

      Biomarker for Niemann Pick Type C Disease (BioNPC)

      Active, not recruiting
      • Niemann-Pick Disease
      • Niemann-Pick Disease, Type C
        • Rostock, Germany
        • +3 more
        May 12, 2021

        DASH Dietary Pattern and Cardiometabolic Risk

        Unknown status
        • Cardiovascular Risk Factor
        • +8 more
        • DASH dietary pattern
        • Toronto, Ontario, Canada
          The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Syn
        Dec 5, 2018

        Meta-analysis of Portfolio Dietary Pattern and Cardiometabolic

        Unknown status
        • Cardiovascular Risk Factor
        • Cholesterol; Lipidosis
        • Portfolio Dietary Pattern
        • NCEP Based Diet
        • Toronto, Ontario, Canada
          The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Syn
        May 21, 2018

        Farber Disease Natural History Study

        Completed
        • Farber Disease
        • +6 more
          • Oakland, California
          • +14 more
          Jan 14, 2020

          Lysosomal Acid Lipase Deficiency Trial in Worldwide (Sebelipase Alfa)

          Completed
          • Lysosomal Acid Lipase Deficiency
          • Sebelipase Alfa
          • Chicago, Illinois
          • +18 more
          Nov 20, 2019

          Gaucher Disease, Type 1, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease Trial in Worldwide (Eliglustat

          Completed
          • Gaucher Disease, Type 1
          • +4 more
          • Eliglustat tartrate
          • New York, New York
          • +16 more
          Dec 22, 2016

          Mixed Hyperlipoproteinemia Trial (Pro-Omega LDL, Placebo)

          Withdrawn
          • Mixed Hyperlipoproteinemia
          • Pro-Omega LDL
          • Placebo
          • (no location specified)
          Dec 10, 2015

          Gaucher Disease Type I, Cerebroside Lipidosis Syndrome, Clucocerebrosidase Deficiency Disease Trial in Coral Springs (Cerezyme

          Completed
          • Gaucher Disease Type I
          • +4 more
          • Cerezyme (imiglucerase for injection)
          • Coral Springs, Florida
            (unnamed)
          Mar 4, 2015

          Gaucher Disease, Type 1, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease Trial in Worldwide (Cerezyme)

          Completed
          • Gaucher Disease, Type 1
          • +4 more
          • Washington, District of Columbia
          • +25 more
          Mar 17, 2015

          Mixed Hyperlipidemia Trial in Seoul (Atorvastatin 10mg, fenofibric acid 135mg, atorvastatin 20mg)

          Unknown status
          • Mixed Hyperlipidemia
          • Atorvastatin 10mg, fenofibric acid 135mg
          • atorvastatin 20mg
          • Seoul, Korea, Republic of
            Severance Hospital, Yonsei University College of Medicine
          Oct 31, 2013

          Neutral Lipid Storage Disease Trial in Maastricht (Fibrate treatment)

          Completed
          • Neutral Lipid Storage Disease
          • Fibrate treatment
          • Maastricht, Limburg, Netherlands
            Maastricht University Medical Center
          May 13, 2013